Pulmonx
Pulmonx is dedicated to improving the lives of patients with severe lung diseases such as COPD and emphysema through innovative bronchoscopic treatments, including the clinically-proven Zephyr Valve. The company's mission is to help patients breathe easier, do more, and enjoy life by providing minimally invasive solutions that reduce lung hyperinflation and improve lung function. Pulmonx develops and commercializes interventional pulmonology devices, including the Zephyr Endobronchial Valve, and offers advanced planning and assessment tools such as StratX® Lung Analysis Reports, the Chartis® Pulmonary Assessment System, and the Patient Selection and Lung Analysis Reports to optimize patient outcomes.
Industries
Nr. of Employees
large (251-1000)
Pulmonx
3000 El Camino Real, Suite 210, Palo Alto, CA 94306
Patents
Methods and devices for passive residual lung volume reduction and functional lung volume expansion
US-12350428-B2
View DetailsMethods, systems, and devices for analyzing lung imaging data to determine collateral ventilation
US-12033320-B2
View Details
Methods and devices for passive residual lung volume reduction and functional lung volume expansion
US-12350428-B2
View DetailsMethods, systems, and devices for analyzing lung imaging data to determine collateral ventilation
US-12033320-B2
View DetailsProducts
Removable implantable endobronchial one-way valves
Removable, implantable one-way valves placed bronchoscopically to occlude targeted airways, promote lobar volume reduction, and improve function in selected patients with hyperinflation and low interlobar collateral ventilation.
Catheter-based pulmonary collateral ventilation assessment system
A bedside catheter and console system that measures lobar flow and pressure intra-procedurally to determine collateral ventilation status and inform eligibility for valve therapy.
Quantitative CT analysis and reporting service for emphysema mapping
CT-based quantitative analysis and standardized reporting to quantify fissure completeness, lobar destruction and volumes to assist target selection and procedural planning.
Bronchoscopic sealant/adhesive delivery system under clinical evaluation
Endobronchial delivery system for sealant/adhesive intended to occlude collateral ventilation channels to convert CV-positive lobes to CV-negative status; currently evaluated in clinical studies.
Removable implantable endobronchial one-way valves
Removable, implantable one-way valves placed bronchoscopically to occlude targeted airways, promote lobar volume reduction, and improve function in selected patients with hyperinflation and low interlobar collateral ventilation.
Catheter-based pulmonary collateral ventilation assessment system
A bedside catheter and console system that measures lobar flow and pressure intra-procedurally to determine collateral ventilation status and inform eligibility for valve therapy.
Quantitative CT analysis and reporting service for emphysema mapping
CT-based quantitative analysis and standardized reporting to quantify fissure completeness, lobar destruction and volumes to assist target selection and procedural planning.
Bronchoscopic sealant/adhesive delivery system under clinical evaluation
Endobronchial delivery system for sealant/adhesive intended to occlude collateral ventilation channels to convert CV-positive lobes to CV-negative status; currently evaluated in clinical studies.
Services
Multi-format clinician education (online, in-person, hands-on) with defined case minimums and outcomes review processes to support procedural competency and inclusion on treatment center lists.
Design and operational support for multicenter randomized trials and post-market studies, including site selection, enrollment management and trial documentation for investigational adjuncts and devices.
Operation of treatment center locators, definition of assessment center equipment requirements, and provision of patient referral resources and reimbursement information to facilitate access to care.
Multi-format clinician education (online, in-person, hands-on) with defined case minimums and outcomes review processes to support procedural competency and inclusion on treatment center lists.
Design and operational support for multicenter randomized trials and post-market studies, including site selection, enrollment management and trial documentation for investigational adjuncts and devices.
Operation of treatment center locators, definition of assessment center equipment requirements, and provision of patient referral resources and reimbursement information to facilitate access to care.
Expertise Areas
- Bronchoscopic lung volume reduction
- Interventional pulmonology procedural training and competency assessment
- Multicenter clinical trial design and operations
- Quantitative imaging-based patient selection and CT emphysema mapping
Key Technologies
- One-way endobronchial valve therapy
- Catheter-based lobar flow and pressure measurement systems
- Balloon occlusion catheters with intra-procedural consoles
- Cloud-based quantitative CT analysis and reporting
News & Updates
Information about ongoing clinical trials evaluating the safety and efficacy of Zephyr Valve and other treatments.
A trial to evaluate the safety and effectiveness of the AeriSeal System to block collateral ventilation in emphysema patients.
Summary of clinical benefits reported in studies, including improvements in lung function, exercise capacity, and quality of life.
Most Studied and Proven Valve for Severe COPD/Emphysema
Zephyr Valve has demonstrated clinically meaningful benefits across multiple randomized controlled trials.
Information about ongoing clinical trials evaluating the safety and efficacy of Zephyr Valve and other treatments.
A trial to evaluate the safety and effectiveness of the AeriSeal System to block collateral ventilation in emphysema patients.
Summary of clinical benefits reported in studies, including improvements in lung function, exercise capacity, and quality of life.
Most Studied and Proven Valve for Severe COPD/Emphysema
Zephyr Valve has demonstrated clinically meaningful benefits across multiple randomized controlled trials.